Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cryomed Aesthetics is an Australia- and New Zealand-focused medical aesthetics company that supplies and supports aesthetic devices, cosmeceuticals, skincare products, and injectables for clinics and practitioners. The business is commercial-stage rather than a therapeutic drug developer, with revenue generated from distribution, service, training, and practice support. Its portfolio includes energy-based and other non-invasive aesthetic technologies used for skin treatment, body contouring, and clinic procedures. The company also provides clinical education, technical servicing, and business development support to customers. Cryomed was founded in 2013 and was acquired in 2020 by EBOS Group, after which it continued operating as an active subsidiary/business unit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cryomed Aesthetics.